Evidence-based recommendations on regorafenib (Stivarga) for previously treated metastatic colorectal cancer in adults.
Commercial arrangement
There is a simple discount patient access scheme for regorafenib. NHS organisations can get details on the Commercial Access and Pricing (CAP) Portal. Non-NHS or...
This guideline covers managing colorectal (bowel) cancer in people aged 18 and over. It aims to
improve quality of life and survival for adults with colorectal cancer through management of local
disease and secondary tumours (metastatic disease).
The recommendations in this guideline were developed befor...
This guideline covers managing colorectal (bowel) cancer in people aged 18 and over. It aims to improve quality of life and survival for adults with colorectal cancer through management of local disease and management of secondary tumours (metastatic disease)....